Bionic Ear: by type (cochlear implant, auditory brainstem implants, and bone-anchored hearing aid); by end use (research institutes, hearing clinics, and hospitals); , And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
Bionic Ear: by type (cochlear implant, auditory brainstem implants, and bone-anchored hearing aid); by end use (research institutes, hearing clinics, and hospitals); , And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
PRODUCT OVERVIEW
Bionic ear, also known as a neural prosthesis, is an electronic device meant to help persons with hearing loss. It has the ability to activate the auditory nerve and send sound signals straight to the brain. A receiver-stimulator and an external sound processor are both fitted behind the ear in the bionic ear. The sound processor also gathers external sound before converting it to a digital code. The digital code is sent to the receiver-stimulator, which is worn behind the ear. Furthermore, the receiver uses the incoming digital code to produce the electrical signals, which are then delivered to the electrode array in the cochlea. Both those who are suffering from profound loss and those who are completely blind can utilize these gadgets.
MARKET HIGHLIGHTS
Global Bionic Ear market is expected to project a notable CAGR of 8.8% in 2031.
Global Bionic Ear to surpass USD 30.2 billion by 2031 from USD 4.9 billion in 2021 at a CAGR of 8.8% in the coming years, i.e., 2021-31. Hearing loss is projected to become more common as the prevalence of hearing impairments rises and the geriatric population grows. According to the World Health Organization, more than 360 million individuals worldwide suffer from hearing loss. Hearing loss is one of the most common ailments in the world.
GLOBAL BIONIC EAR: SEGMENTS
Cochlear implant segment to grow with the highest CAGR during 2021-31
Global Bionic Ear Market is fragmented by type into cochlear implant, auditory brainstem implants, and bone-anchored hearing aid. Electric stimulation of the remaining auditory nerve is the only medical method that can restore partial hearing to a deafened person. It may be a good alternative for patients who have significant hearing loss due to inner ear damage and are no longer able to use hearing aids.
Research institutes segment to grow with the highest CAGR during 2021-31
Global Bionic Ear market is segmented by end use into research institutes, hearing clinics, and hospitals. Research institutes are organizations that conduct a variety of studies on a variety of topics. The number of studies on bionic ears has increased in recent years. The establishment of research institutes is aided by increased financing for research projects. Rising financing for research initiatives has resulted in an increase of research institutes, boosting the segment's growth.
MARKET DYNAMICS
Drivers
Hearing loss is becoming more common
Demand for minimally invasive surgical procedures is expected to grow, boosting the market
Restraint
A regulatory mandate
GLOBAL BIONIC EAR:
Key Players
Bionic Ear Segments:
PRODUCT OVERVIEW
Bionic ear, also known as a neural prosthesis, is an electronic device meant to help persons with hearing loss. It has the ability to activate the auditory nerve and send sound signals straight to the brain. A receiver-stimulator and an external sound processor are both fitted behind the ear in the bionic ear. The sound processor also gathers external sound before converting it to a digital code. The digital code is sent to the receiver-stimulator, which is worn behind the ear. Furthermore, the receiver uses the incoming digital code to produce the electrical signals, which are then delivered to the electrode array in the cochlea. Both those who are suffering from profound loss and those who are completely blind can utilize these gadgets.
MARKET HIGHLIGHTS
Global Bionic Ear market is expected to project a notable CAGR of 8.8% in 2031.
Global Bionic Ear to surpass USD 30.2 billion by 2031 from USD 4.9 billion in 2021 at a CAGR of 8.8% in the coming years, i.e., 2021-31. Hearing loss is projected to become more common as the prevalence of hearing impairments rises and the geriatric population grows. According to the World Health Organization, more than 360 million individuals worldwide suffer from hearing loss. Hearing loss is one of the most common ailments in the world.
GLOBAL BIONIC EAR: SEGMENTS
Cochlear implant segment to grow with the highest CAGR during 2021-31
Global Bionic Ear Market is fragmented by type into cochlear implant, auditory brainstem implants, and bone-anchored hearing aid. Electric stimulation of the remaining auditory nerve is the only medical method that can restore partial hearing to a deafened person. It may be a good alternative for patients who have significant hearing loss due to inner ear damage and are no longer able to use hearing aids.
Research institutes segment to grow with the highest CAGR during 2021-31
Global Bionic Ear market is segmented by end use into research institutes, hearing clinics, and hospitals. Research institutes are organizations that conduct a variety of studies on a variety of topics. The number of studies on bionic ears has increased in recent years. The establishment of research institutes is aided by increased financing for research projects. Rising financing for research initiatives has resulted in an increase of research institutes, boosting the segment's growth.
MARKET DYNAMICS
Drivers
Hearing loss is becoming more common
Demand for minimally invasive surgical procedures is expected to grow, boosting the market
Restraint
A regulatory mandate
GLOBAL BIONIC EAR:
Key Players
- Advanced Bionics (US)
- Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
- Sonova (Switzerland)
- Cochlear (Australia)
- MED-EL (Austria)
- WS Audiology (Singapore)
- Oticon (Denmark)
- Hangzhou Nurotron (China)
- Listent Medical (China)
- Medtronic PLC (Ireland)
- Edward Lifesciences Corporation (US)
- Other Prominent Players
Bionic Ear Segments:
- By Type
- cochlear implant
- auditory brainstem implants
- bone-anchored hearing aid
- By End use
- research institutes
- hearing clinics
- hospitals
- Bionic Ear Dynamics
- Bionic Ear Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
- Reasons to Purchase this Report
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1 EXECUTIVE SUMMARY
2 GLOBAL BIONIC EAR MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL BIONIC EAR MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL BIONIC EAR MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL BIONIC EAR MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By type: Market Share (2020-2031F)
12.2.1. Cochlear implant, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Auditory brainstem implants, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Bone-anchored hearing aid, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By end use: Market Share (2020-2031F)
12.3.1. Research institutes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Hearing clinics, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. Advanced Bionics (US)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Sonova (Switzerland)
13.3. Cochlear (Australia)
13.4. MED-EL (Austria)
13.5. WS Audiology (Singapore)
13.6. Oticon (Denmark)
13.7. Hangzhou Nurotron (China)
13.8. Listent Medical (China)
13.9. Medtronic PLC (Ireland)
13.10. Edward Lifesciences Corporation (US)
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2 GLOBAL BIONIC EAR MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL BIONIC EAR MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL BIONIC EAR MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL BIONIC EAR MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By type: Market Share (2020-2031F)
12.2.1. Cochlear implant, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Auditory brainstem implants, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Bone-anchored hearing aid, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By end use: Market Share (2020-2031F)
12.3.1. Research institutes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Hearing clinics, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. Advanced Bionics (US)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Sonova (Switzerland)
13.3. Cochlear (Australia)
13.4. MED-EL (Austria)
13.5. WS Audiology (Singapore)
13.6. Oticon (Denmark)
13.7. Hangzhou Nurotron (China)
13.8. Listent Medical (China)
13.9. Medtronic PLC (Ireland)
13.10. Edward Lifesciences Corporation (US)
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
